Citius Pharmaceuticals, Inc. Increase (Decrease) in Interest Payable, Net
Citius Pharmaceuticals, Inc. (CTXR) reported Increase (Decrease) in Interest Payable, Net of $663 for the 9-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2014-08-14
- Citius Pharmaceuticals, Inc. increase (decrease) in interest payable, net for the quarter ending 2014-06-30 was $322.00, a 82.70% decline year-over-year.
- Citius Pharmaceuticals, Inc. increase (decrease) in interest payable, net for the quarter ending 2014-03-31 was $274.00, a 41.08% decline year-over-year.
- Citius Pharmaceuticals, Inc. increase (decrease) in interest payable, net for the quarter ending 2013-12-31 was $67.00, a 80.69% decline year-over-year.
- Citius Pharmaceuticals, Inc. increase (decrease) in interest payable, net for the quarter ending 2013-09-30 was -$1.93K, a 365.38% decline year-over-year.
- Citius Pharmaceuticals, Inc. increase (decrease) in interest payable, net for fiscal 2013 was $741.00, a 7.95% decline from fiscal 2012.
- Citius Pharmaceuticals, Inc. increase (decrease) in interest payable, net for fiscal 2012 was $805.00.
- Citius Pharmaceuticals, Inc. increase (decrease) in interest payable, net for fiscal 2011 was $0.00.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 3 month as first filed | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 6 month as first filed | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month | Increase (Decrease) in Interest Payable, Net 12 month as first filed | Increase (Decrease) in Interest Payable, Net 13 month | Increase (Decrease) in Interest Payable, Net 16 month | Increase (Decrease) in Interest Payable, Net 19 month | Increase (Decrease) in Interest Payable, Net 22 month | Increase (Decrease) in Interest Payable, Net 25 month | Increase (Decrease) in Interest Payable, Net 28 month | Increase (Decrease) in Interest Payable, Net 31 month | Increase (Decrease) in Interest Payable, Net 34 month | Increase (Decrease) in Interest Payable, Net 37 month | Increase (Decrease) in Interest Payable, Net 40 month | Increase (Decrease) in Interest Payable, Net 43 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | $322.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-14 | $596.00 derived: sum of 2 quarters · filed 2014-08-14 | $663.00 10-Q · filed 2014-08-14 | -$1.27K derived: sum of 4 quarters · filed 2014-08-14 | ||||||||||||||
| 2014-03-31 | $274.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-15 | $341.00 10-Q · filed 2014-05-15 | -$1.59K derived: sum of 3 quarters · filed 2014-05-15 | $270.00 derived: sum of 4 quarters · filed 2014-08-14 | $1.89K 10-Q · filed 2014-05-15 | |||||||||||||
| 2013-12-31 | $67.00 10-Q · filed 2014-02-19 | -$1.86K derived: sum of 2 quarters · filed 2014-02-19 | -$4.00 derived: sum of 3 quarters · filed 2014-08-14 | $461.00 derived: sum of 4 quarters · filed 2014-08-14 | $1.61K 10-Q · filed 2014-02-19 | |||||||||||||
| 2013-09-30 | -$1.93K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | -$71.00 derived: sum of 2 quarters · filed 2014-08-14 | $394.00 derived: sum of 3 quarters · filed 2014-08-14 | $741.00 10-K · filed 2014-02-06 | $1.55K 10-K · filed 2014-02-06 | |||||||||||||
| 2013-06-30 | $1.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-14 | $2.33K derived: sum of 2 quarters · filed 2014-08-14 | $2.67K 10-Q · filed 2014-08-14 | $3.40K derived: sum of 4 quarters · filed 2014-08-14 | $3.48K 10-Q · filed 2013-09-18 | |||||||||||||
| 2013-03-31 | $465.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-15 | $812.00 10-Q · filed 2014-05-15 | $1.54K derived: sum of 3 quarters · filed 2014-05-15 | $1.62K derived: sum of 4 quarters · filed 2014-05-15 | $1.62K 10-Q · filed 2013-05-13 | |||||||||||||
| 2012-12-31 | $347.00 10-Q · filed 2014-02-19 | $1.07K derived: sum of 2 quarters · filed 2014-02-19 | $1.15K derived: sum of 3 quarters · filed 2014-02-19 | $1.15K derived: sum of 4 quarters · filed 2014-02-19 | $1.15K 10-Q · filed 2013-02-08 | |||||||||||||
| 2012-09-30 | $728.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $805.00 derived: sum of 2 quarters · filed 2014-02-06 | $805.00 derived: sum of 3 quarters · filed 2014-02-06 | $805.00 10-K · filed 2014-02-06 | $805.00 10-K · filed 2013-01-15 | |||||||||||||
| 2012-06-30 | $77.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-18 | $77.00 derived: sum of 2 quarters · filed 2013-09-18 | $77.00 10-Q · filed 2013-09-18 | $77.00 10-Q · filed 2012-08-17 | ||||||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-13 | $0.00 10-Q · filed 2013-05-13 | $883.00 10-Q · filed 2012-05-11 | $1.59K 10-Q · filed 2012-05-11 | ||||||||||||||
| 2011-12-31 | $0.00 10-Q · filed 2013-02-08 | $372.00 10-Q · filed 2012-02-14 | $1.08K 10-Q · filed 2012-02-14 | |||||||||||||||
| 2011-09-30 | $0.00 10-K · filed 2013-01-15 | $704.00 10-K · filed 2012-01-13 | $704.00 10-K · filed 2012-01-13 | |||||||||||||||
| 2011-03-31 | $154.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-11 | $167.00 10-Q · filed 2012-05-11 | ||||||||||||||||
| 2010-12-31 | $13.00 10-Q · filed 2012-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |